$ARCT news
The latest ARCT stock news: headlines, filings, AI summaries and sentiment for $ARCT, updated around the clock.
- Arcturus Therapeutics Reports Q3 2026 Results with Narrowing Net Loss and Strong Cash Position
- Arcturus Therapeutics Announces Phase II Dosing Timeline for ARCT-2601 and LUNAR 2.0 Platform Advancements
- Arcturus Therapeutics Holdings Inc. - 10-Q Filing
- Arcturus Therapeutics Holdings Inc. - 8-K Filing
- Citi Upgrades Arcturus Therapeutics to Buy Following Positive Trial Data
- Arcturus Reports Positive Mid-Stage Trial Results for ARCT-810 in OTC Deficiency
- Arcturus Therapeutics Holdings Inc. - 8-K Filing
- Arcturus and Moderna Stocks Drop Following BioNTech's Cancer Vaccine Trial Halt
- Arcturus Reports Q1 2026 Earnings and Clinical Progress
- Arcturus Therapeutics Holdings Inc. - 10-Q Filing
- Arcturus Therapeutics Holdings Inc. - 8-K Filing